Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Assets (2019 - 2025)

Historic Return on Assets for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.06%.

  • Eton Pharmaceuticals' Return on Assets rose 1000.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.07% for FY2024, which is 400.0% down from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Return on Assets stood at 0.06%, which was up 1000.0% from 0.04% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Return on Assets ranged from a high of 0.07% in Q3 2023 and a low of 0.52% during Q2 2022
  • For the 5-year period, Eton Pharmaceuticals' Return on Assets averaged around 0.2%, with its median value being 0.16% (2024).
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 14100bps in 2021, then tumbled by -3200bps in 2022.
  • Eton Pharmaceuticals' Return on Assets (Quarter) stood at 0.07% in 2021, then tumbled by -436bps to 0.39% in 2022, then surged by 92bps to 0.03% in 2023, then plummeted by -131bps to 0.07% in 2024, then grew by 5bps to 0.06% in 2025.
  • Its Return on Assets was 0.06% in Q3 2025, compared to 0.04% in Q2 2025 and 0.06% in Q1 2025.